FX-300

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFX-300
Drug Alias Namepeptide leukocyte migration inhibitor (Ikaria)peptide leukocyte migration inhibitor (Fibrex Medical)FX-300
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionLeukocyte migration inhibitors
TargetsUpdating
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustria
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFibrex Medical Research & Development Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIkaria IncFibrex Medical Research & Development Gmbh
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A